OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
34 hedge funds and large institutions have $5.31M invested in OncoSec Medical Incorporated in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 6 closing their positions.
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
10% more funds holding
Funds holding: 31 → 34 (+3)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
61% less capital invested
Capital invested by funds: $13.8M → $5.31M (-$8.45M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$224K |
| 2 |
SM
Salzhauer Michael
|
+$67.7K |
| 3 |
SFP
Sandbox Financial Partners
Bethesda,
Maryland
|
+$57.6K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$53.9K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$40K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$1.21M |
| 2 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$371K |
| 3 |
Two Sigma Advisers
New York
|
-$215K |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$78.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$53.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $2K | -$1.82K | -54 | -35% |
|
27
Morgan Stanley
New York
| $2K | -$169 | -5 | -7% |
|
|
BFEC
28
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $1K | – | – | – |
|
29
Federated Hermes
Pittsburgh,
Pennsylvania
| $1K | +$237 | +7 | New |
|
|
JGC
30
J. Goldman & Co
New York
| – | -$1.21M | -35,920 | Closed |
|
31
Goldman Sachs
New York
| – | -$53K | -1,132 | Closed |
|
32
Walleye Capital
New York
| – | -$48 | -1,018 | Closed |
|
33
Envestnet Asset Management
Chicago,
Illinois
| – | -$45K | -955 | Closed |
|
34
HighTower Advisors
Chicago,
Illinois
| – | -$45K | -941 | Closed |
|
|
SPC
35
Sigma Planning Corp
Ann Arbor,
Michigan
| – | -$29K | -614 | Closed |
|
36
Osaic Holdings
Scottsdale,
Arizona
| – | -$11.5K | -341 | -99% |
|
|
CG
37
Cutler Group
San Francisco,
California
| – | -$777 | -23 | -42% |
|
38
Citigroup
New York
| – | +$169 | +5 | New |
|
39
Simplex Trading
Chicago,
Illinois
| – | +$744 | +22 | New |
|
ONCS Hedge Fund Activity: Q4 2021 in Review
34 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2021, worth a combined $5.31M — down 61% from $13.8M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ONCS positions and 6 closed out — a net gain of 3 holders — while 8 added to existing stakes and 10 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $224K. The largest seller was J. Goldman & Co, exiting entirely with an estimated $1.21M sold.
- 34 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2021, up from 31 in Q3 2021.
- Funds reported $5.31M of OncoSec Medical Incorporated stock for Q4 2021, down 61% quarter-over-quarter.
- 9 funds opened new OncoSec Medical Incorporated positions in Q4 2021 and 6 closed out, a net change of +3 holders.
- The largest OncoSec Medical Incorporated buyer in Q4 2021 was Renaissance Technologies, an estimated $224K added.
- The largest OncoSec Medical Incorporated seller in Q4 2021 was J. Goldman & Co, an estimated $1.21M sold.
Based on aggregated 13F filings for Q4 2021.